Absence of entecavir resistance emergence in lamivudine-refractory patients treated for at least one year with entecavir in study A1463-014

被引:3
作者
Colonno, R [1 ]
Rose, R [1 ]
Cross, A [1 ]
Hindes, R [1 ]
Tenney, D [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
关键词
D O I
10.1016/S0168-8278(04)90043-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
43
引用
收藏
页码:16 / 16
页数:1
相关论文
empty
未找到相关数据